Merck pares 2010 forecast, despite beat in quarter – Reuters


Kansas City Star

Merck pares 2010 forecast, despite beat in quarter
Reuters
N) issued a more cautious 2010 profit outlook on Friday and reported disappointing second-quarter sales of its vaccines and Singulair asthma drug,
Merck 2Q Profit Drops 52% On Charges; Key Drug Sales WeakerWall Street Journal
Merck's profit drops on merger costs, revampMarketWatch
Merck's 2Q net drops on higher costs, chargesThe Associated Press
Barron’s –Wall Street Pit (blog)
all 216 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *